Navigation Links
Watson to Host Conference Call and Webcast to Discuss Second Quarter 2011 Earnings
Date:6/30/2011

PARSIPPANY, N.J., June 30, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading integrated global pharmaceutical company, announced today that the Company intends to release its second quarter 2011 financial results on Tuesday, July 26, 2011 prior to the open of the U.S. financial markets.  The Company will also host a conference call and webcast at 8:30 a.m. Eastern Time on July 26, 2011 to discuss its financial results and provide an update on the Company's outlook for 2011.  The dial-in number to access the call is US/Canada (877) 251-7980, International (706) 643-1573, and the Conference ID is 79602222.

(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)

A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 12:00 midnight Eastern Time on August 9, 2011.  The replay may be accessed by dialing (800) 642-1687 and entering the same Conference ID above.  From international locations, the replay may be accessed by dialing (706) 645-9291.  To access the webcast, go to Watson's Investor Relations Web site at http://ir.watson.com.  A replay of the webcast will also be available.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com. CONTACTS:Investors:Patty
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson Announces Expansion of Salt Lake City, Utah Pharmaceutical R&D and Manufacturing Facility
2. Watson to Present at 2011 Wells Fargo Securities Healthcare Conference
3. Watson Confirms AVODART(R) Patent Challenge
4. Watson Confirms Court Decision Rejecting Tevas Motion to Prevent Launch of Generic SEASONIQUE®
5. Watsons Nabumetone Tablets Receive FDA Approval
6. Watson Confirms Pataday™ Patent Challenge
7. Watson Confirms Viagra® Patent Challenge
8. Watson to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference
9. Watson Launches Generic AMRIX®
10. Watson Launches Generic Concerta®
11. Watson Pharmaceuticals to Webcast Annual Meeting of Stockholders on May 13th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014 PositiveID Corp. (OTCQB: PSID), ... , is an emerging player in the bio-threat ... bio-threat detection and rapid medical testing. The Company,s ... Bio-agent Autonomous Networked Detector), was developed under contract ... Science & Technology directorate, and $30 million of ...
(Date:7/23/2014)... PLYMOUTH MEETING, Pa. , July 23, ... MKT: INO) today announced successful results from ... of VGX-3100 in women with biopsy-proven cervical ... papillomavirus (HPV) types 16 or 18. Treatment ... histopathological regression of CIN2/3 to CIN1 or ...
(Date:7/23/2014)... , July 23, 2014  Nearly 8,000 attendees ... for Cardinal Health,s annual Retail Business Conference (RBC), taking ... Convention Center. This year,s event encourages pharmacists to "Lead ... their communities and for their future. ... owners to network with their peers and learn new ...
Breaking Medicine Technology:PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6
... BIRMINGHAM, Ala., March 10, 2011 PNP ... from research conducted at Southern Research Institute and The ... that several major objectives have been reached in the ... for the treatment of cancer. "A number ...
... InstaCare Corp. (OTC Bulletin Board: ISCR ), ... the chronically ill, a leading fulfillment provider of direct to ... pending cell phone centric e -health products and technologies, ... pharmaceutical e-detailing Mobile Health Media System, known as ...
Cached Medicine Technology:PNP Therapeutics Meets Important Financial and Regulatory Objectives in Development of New Cancer Therapies 2InstaCare Announces Ready for Market MD@Detail Mobile Health Media System for Pharmaceutical e-Detailing 2InstaCare Announces Ready for Market MD@Detail Mobile Health Media System for Pharmaceutical e-Detailing 3
(Date:7/23/2014)... Texas Physical Therapy Specialists (TexPTS) is proud to ... Liberty Hill, Parmer, Balcones, and Georgetown clinics have received ... Certified Specialist (OCS) or Sports Certified Specialist ... Tony Lauretta, PT, DPT, OCS, Jason Brown, PT, DPT, ... DPT, OCS, and Mary Grimberg, PT, DPT, OCS received ...
(Date:7/23/2014)... the likelihood of forming false memories, according to research ... the Association for Psychological Science. , In a study ... University of California, Irvine and colleagues, sleep-deprived people who ... read false information about the photos were more likely ... than were those who got a full night,s sleep. ...
(Date:7/23/2014)... CarePoint Health is proud to announce ... Jersey to receive the da Vinci® Xi™ Surgical System, ... da Vinci series. This 4th generation robotic platform is ... innovation. The intuitive da Vinci Xi has broad capabilities ... minimally invasive and complex surgical procedures. The acquisition of ...
(Date:7/23/2014)... The North American market was valued at $985.4 million ... CAGR of 10.79%, to reach $1,801.1 million by 2018. Organobromines ... North American Bromine Market report defines and segments the bromine ... Browse through the TOC of the North American Bromine Market ... This also provides a glimpse of the segmentation in the ...
(Date:7/23/2014)... Recently, Agebc.com has launched its new ... is announcing a promotion of wedding dresses. According to ... at the end of this month. , The beautiful ... like A-line, mermaid, ball-gown, empire, and more. Agebc.com is ... special-occasion dresses for women, and the company is devoted ...
Breaking Medicine News(10 mins):Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 2Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 3Health News:Sleep deprivation may increase susceptibility to false memories 2Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 2Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 3Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 4Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 4Health News:Agebc.com Launched Its New Collection of Wedding Dresses 2
... Bird, a molecular geneticist at the University of Edinburgh, Scotland, ... of a protein called Uqcrc1 in the brains of mouse ... which are the powerhouses of the cells to work overtime. ... mitochondrial gene has been linked to Rett Syndrome. The co-author ...
... that the male survivors of childhood sexual abuse ... understood// many health care practitioners as well as ... male and female childhood sexual survivors usually exhibit ... encounters with health care professionals, there are gender ...
... that New Orleans seems to be going throuogh a ... intensity rarely seen in the US. ,Suicide ... struck, 10 months ago. To make matters worse the ... the police department to deal with the large number ...
... University and the Celiac Sprue Research Foundation have claimed ... celiac sprue// that is an inherited inflammatory disorder of ... around the world. The two research studies that have ... Biology have opened the way for clinical testing with ...
... Cadbury Ireland had on the 23rd June recalled almost ... move because there are fears// that those bars may ... the company has said that there were minute traces ... levels that stipulated by the scientific standards for any ...
... to use a protein that has been originally isolated from ... genetically// modified technology. ,The parent company, Unilever, have ... ice creams that are of low-calorie, and low fat. They ... newer versions of their best selling products like the Cornetto, ...
Cached Medicine News:Health News:Researchers Have Linked Rett Syndrome to Mitochondrial Gene 2Health News:Researchers Have Linked Rett Syndrome to Mitochondrial Gene 3Health News:Sexually Abused Males Found Struggling In heir relations with Healthcare Providers 2Health News:Scientists Discover Non-dietary Therapy For Celiac Diseases 2Health News:Wall's To Develop Low-fat Ice-cream Using Fish Blood 2
Thermal Cautery, Sterile Single-Use Units for Vasectomy. Burns at approximately 1200C (2200 F). Integrated unit includes handle, vasectomy tip, & AA batteries. Box of 10 units. Discounts on 2 or more...
Li Brand™ Ringed Forceps. ("fixation clamp") For NSV and other procedures. Ring diameter approximately 3.5 mm. Manufactured exclusively for AMI to exacting specifications by a German company....
... users of "completely-in-the-canal" (CIC) instruments of ... ,Impressions of your ears are required. ... the ear are distributed via our ... These providers include audiologists and hearing ...
... bronchoscopy: The HF-compatible V series from Pentax, ... bronchoscopes are measured., ,The HF-compatible series ... FB-19TV, FB-18V and FB-15V models along with ... FB-8V, offer much better image quality thanks ...
Medicine Products: